Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: There is an ongoing debate regarding the effect of renal impairment on CYP related metabolic activities. The possible effect of renal impairment on hepatic CYP2B6 activity, or on bupropion pharmacokinetics in renally impaired subjects without dialysis treatm...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Turpeinen, Miia, Koivuviita, Niina, Tolonen, Ari, Reponen, Petri, Lundgren, Stefan, Miettunen, Jouko, Metsärinne, Kaj, Rane, Anders, Pelkonen, Olavi, Laine, Kari
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2007
Konular:
Pharmacokinetics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2000634/
https://ncbi.nlm.nih.gov/pubmed/17335546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02866.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller